Products
The BD AutoShield Duo™ pen needle is a safety pen needle that comes in a 5-mm size to help facilitate safe insulin injections. Featuring patented automatic dual-protection shields on both ends of the needle, it helps prevent needlestick exposure and injury during injection and disposal. Conveniently, the BD AutoShield Duo™ pen needle is compatible with widely available diabetes medication pens in the United States.
-
United States
North America
South America
Europe
Middle East / Africa
Asia / Pacific
-
Login
Support
Sales
1.844.8.BD.LIFE (1.844.823.5433)
Sales Form
Please fill out the form and a sales representative will get
in touch with you.
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
Customer Service
1.888.367.9539
- Overview
- Products & Accessories
- EIFU & Resources
true
Reduced risk of needlestick injury (NSI)
The pen needle features shields over both the front-end and back-end needles and does not require a pinch-up.*
OSHA compliance
The pen needle helps meet the OSHA requirement to evaluate safer devices as they become available.1
Single-handed injection technique
To minimize the risk of NSI through a skinfold, the use of shorter (4-mm and 5-mm) pen needles without a skinfold is recommended.2*
Reduced IM Injection Risk
By delivering subcutaneous injections, the 5-mm pen needle helps reduce the risk of intramuscular (IM) injections that can increase the risk of hypoglycemia in patients.3
Thin Wall Technology
Our needles retain their fine external dimensions but with a wider inner diameter.
* Children from 2 to 6 years old, extremely lean adults or people with loose skin may need to use a pinch-up technique.
1. Occupational Safety and Health Administration. Bloodborne pathogens. 29 CFR §1910.1030.
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=10051.
2. Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231-1255.
3. American Diabetes Association. Standards of Medical Care in Diabetes-2022, Diabetes Care 2022;45(Suply.1):S1-S212
true
* Children from 2 to 6 years old, extremely lean adults or people with loose skin may need to use a pinch-up technique.
1. Occupational Safety and Health Administration. Bloodborne pathogens. 29 CFR §1910.1030.
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=10051.
2. Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231-1255.
3. American Diabetes Association. Standards of Medical Care in Diabetes-2022, Diabetes Care 2022;45(Suply.1):S1-S212
true
Literature
BD's collection of literature on industry and on our offerings gives you information you can use to continue striving for excellence.
Learn more
Training
BD offers training resources to help improve your clinical practices as part of our goal of advancing the world of health.
Learn more
Events
BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.
Learn more
Case Studies
BD promotes clinical excellence by providing various resources on best practices, clinical innovations and industry trends in healthcare.
Learn more
* Children from 2 to 6 years old, extremely lean adults or people with loose skin may need to use a pinch-up technique.
1. Occupational Safety and Health Administration. Bloodborne pathogens. 29 CFR §1910.1030.
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=10051.
2. Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231-1255.
3. American Diabetes Association. Standards of Medical Care in Diabetes-2022, Diabetes Care 2022;45(Suply.1):S1-S212
true